|
A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
RECRUITINGN/ASponsored by Massachusetts General Hospital
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2024-04-19
Est. completion2026-06
Eligibility
Age25 Years – 39 Years
Healthy vol.Accepted
Locations4 sites
View on ClinicalTrials.gov →
NCT06172907
Summary
The purpose of this pilot study is to examine the feasibility and acceptability of a brief psychotherapy intervention to improve psychosocial coping and maintain couple relationships among young adults (aged 25-39) with cancer and their caregiving partners.
Eligibility
Age: 25 Years – 39 YearsHealthy volunteers accepted
Inclusion Criteria: * Either: (1) Currently receiving active cancer treatment (n=5) or are within two years of completing active treatment (n=5) at Massachusetts General Cancer Center (MGHCC), located in Boston, Massachusetts, United States, OR (2) are the partner of an individual between the ages of 25-39 who is currently receiving treatment at MGHCC (n=5) or who has completed cancer treatment at MGHCC within the past two years (n=5) * Either: (1) Indicates a score ≥4 on the National Comprehensive Cancer Network (NCCN) adapted distress thermometer study screening questions, OR (2) are the partner of a participant indicating a score ≥4 on the NCCN adapted distress thermometer study screening questions * English-speaking Exclusion Criteria: • Uncontrolled psychosis, active suicidal ideation, or cognitive impairment
Conditions6
CancerCaregiver BurdenCoping SkillsCouplesPsychological DistressSurvivorship
Locations4 sites
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2024-04-19
Est. completion2026-06
Eligibility
Age25 Years – 39 Years
Healthy vol.Accepted
Locations4 sites
View on ClinicalTrials.gov →
NCT06172907